BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19372795)

  • 1. The latent reservoir for HIV-1 in resting CD4+ T cells: a barrier to cure.
    Siliciano JD; Siliciano RF
    Curr Opin HIV AIDS; 2006 Mar; 1(2):121-8. PubMed ID: 19372795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latent reservoir for HIV-1 in resting CD4+ T cells and other viral reservoirs during chronic infection: insights from treatment and treatment-interruption trials.
    Haggerty CM; Pitt E; Siliciano RF
    Curr Opin HIV AIDS; 2006 Jan; 1(1):62-8. PubMed ID: 19372786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
    Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
    Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
    Siliciano RF
    Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term latent reservoir for HIV-1: discovery and clinical implications.
    Siliciano JD; Siliciano RF
    J Antimicrob Chemother; 2004 Jul; 54(1):6-9. PubMed ID: 15163657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the HIV Latency and the Role of Cytokines.
    Hokello J; Sharma AL; Dimri M; Tyagi M
    Pathogens; 2019 Sep; 8(3):. PubMed ID: 31487807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
    Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
    AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental approaches to the study of HIV-1 latency.
    Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF
    Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attacking latent HIV provirus: from mechanism to therapeutic strategies.
    Archin NM; Margolis DM
    Curr Opin HIV AIDS; 2006 Mar; 1(2):134-40. PubMed ID: 19372797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to engage Cofilin.
    Bukrinsky M
    Retrovirology; 2008 Sep; 5():85. PubMed ID: 18808680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent HIV-1 reservoirs in children: considerations for therapy.
    Persaud D
    Curr Opin HIV AIDS; 2006 Mar; 1(2):174-8. PubMed ID: 19372804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
    Chun TW; Justement JS; Lempicki RA; Yang J; Dennis G; Hallahan CW; Sanford C; Pandya P; Liu S; McLaughlin M; Ehler LA; Moir S; Fauci AS
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1908-13. PubMed ID: 12552096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efforts to eliminate the latent reservoir in resting CD4+ T cells: strategies for curing HIV-1 infection.
    Ho YC; Siliciano JD
    J Virus Erad; 2015 Oct; 1(4):229-31. PubMed ID: 27482420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to target non-T-cell HIV reservoirs.
    Sacha JB; Ndhlovu LC
    Curr Opin HIV AIDS; 2016 Jul; 11(4):376-82. PubMed ID: 27023285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.
    Finzi D; Blankson J; Siliciano JD; Margolick JB; Chadwick K; Pierson T; Smith K; Lisziewicz J; Lori F; Flexner C; Quinn TC; Chaisson RE; Rosenberg E; Walker B; Gange S; Gallant J; Siliciano RF
    Nat Med; 1999 May; 5(5):512-7. PubMed ID: 10229227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.